Back
Sage Therapeutics Stock Predictions
Apple's Drop in iPhone Sales Opens the Door for New Entrant
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
28
SAGE
Sage Therapeutics
Last Price:
$7.08
Seasonality Move:
7.04%
7 Day Trial
ALL ACCESS PASS
$
7
Meet the founder that's revolutionizing smartphones
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.Sage Therapeutics Stock Forecast
-
Over the next 52 weeks, Sage Therapeutics has on average historically risen by 15.6% based on the past 10 years of stock performance.
-
Sage Therapeutics has risen higher in 5 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
-
Is Sage Therapeutics Stock Undervalued?The current Sage Therapeutics [SAGE] share price is $6.91. The Score for SAGE is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
-
SAGE is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
Will Sage Therapeutics Stock Go Up Next Year?
-
Over the next 52 weeks, Sage Therapeutics has on average historically risen by 15.6% based on the past 10 years of stock performance.
Sage Therapeutics Stock Rating
Sell
28
Sage Therapeutics (SAGE)
is a Sell
Is Sage Therapeutics overpriced?
-
Sage Therapeutics has risen higher in 5 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
Sage Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
sagerx.com
52-Week Data
52-Week High:
16.81
52-Week Low:
4.62
Prediction Charts
Market Cap:
424.8M
Price in USD:
6.91
Volume:
1.1M
Beta:
1.29
Technical Analysis
SMA50:
7.48
SMA100:
6.66
SMA200:
7.64
52-Wk Change:
-57.99%
Stock Predictions
-
Is Sage Therapeutics stock public?Yes, Sage Therapeutics is a publicly traded company.
-
What is the Sage Therapeutics stock quote today?The Sage Therapeutics stock price is 6.91 USD today.
-
How to buy Sage Therapeutics stock online?You can buy Sage Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Mar-24 | 8.15 | 8.21 | 8.26 | 8.09 |
| Mar-25 | 8.05 | 8.53 | 8.56 | 7.99 |
| Mar-26 | 8.57 | 8.60 | 8.68 | 8.40 |
| Mar-27 | 8.57 | 8.66 | 8.71 | 8.53 |
| Mar-28 | 8.69 | 8.28 | 8.81 | 8.24 |
| Mar-31 | 8.11 | 7.95 | 8.11 | 7.89 |
| Apr-1 | 7.96 | 7.86 | 7.96 | 7.72 |
| Apr-2 | 7.82 | 7.77 | 7.97 | 7.70 |
| Apr-3 | 7.68 | 7.37 | 7.68 | 7.35 |
| Apr-4 | 7.28 | 6.86 | 7.31 | 6.77 |
| Apr-7 | 6.65 | 6.66 | 6.91 | 6.42 |
| Apr-8 | 6.84 | 6.39 | 6.91 | 6.34 |
| Apr-9 | 6.32 | 6.92 | 7.10 | 6.14 |
| Apr-10 | 6.78 | 6.91 | 7.02 | 6.70 |
Sage Therapeutics Earnings
Sage Therapeutics Earnings Report: Per Share Sage Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
Sage Therapeutics Forecast Revenue Growth
Sage Therapeutics Stock Analysis: Historical quarterly revenues per share for Sage Therapeutics and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $0.71 per share, an increase next quarter of $0.41 per share, an increase this year of $2.68 per share, and an increase next year of $1.19 per share.
* Sage Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.